Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 1923607, 4 pages
https://doi.org/10.1155/2017/1923607
Case Report

Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia

Interfaith Medical Center, Brooklyn, NY, USA

Correspondence should be addressed to Ramesh Kumar Pandey; moc.liamg@779.pkr.rd

Received 14 January 2017; Revised 2 March 2017; Accepted 23 March 2017; Published 4 April 2017

Academic Editor: Kazunori Nakase

Copyright © 2017 Ramesh Kumar Pandey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Moschcowitz, “An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries; an undescribed disease,” The American Journal of Medicine, vol. 13, no. 5, pp. 567–569, 1952. View at Google Scholar
  2. M. Furlan, R. Robles, and B. Lammle, “Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis,” Blood, vol. 87, no. 10, pp. 4223–4234, 1996. View at Google Scholar
  3. T. L. Hurskainen, S. Hirohata, M. F. Seldin, and S. S. Apte, “ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25555–25563, 1999. View at Google Scholar
  4. H. M. Tsai, “Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion,” Blood, vol. 87, no. 10, pp. 4235–4244, 1996. View at Google Scholar
  5. M. Furlan, R. Robles, M. Solenthaler, M. Wassmer, P. Sandoz, and B. Lammle, “Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura,” Blood, vol. 89, no. 9, pp. 3097–3103, 1997. View at Google Scholar
  6. G. G. Levy, W. C. Nichols, E. C. Lian et al., “Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura,” Nature, vol. 413, no. 6855, pp. 488–494, 2001. View at Google Scholar
  7. H. M. Tsai and E. C. Lian, “Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1585–1594, 1998. View at Google Scholar
  8. M. Furlan, R. Robles, M. Galbusera et al., “von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1578–1584, 1998. View at Google Scholar
  9. P. M. Beigelman, “Variants of the platelet thrombosis syndrome and their relationship to disseminated lupus,” AMA Archives of Pathology, vol. 51, no. 2, pp. 213–223, 1951. View at Google Scholar
  10. A. Dekker, M. E. O'Brien, and R. J. Cammarata, “The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus: a report of two cases with successful treatment of one,” The American Journal of the Medical Sciences, vol. 267, no. 4, pp. 243–249, 1974. View at Google Scholar
  11. A. M. Kosloske and A. V. Pisciotta, “The syndrome of thrombotic thrombocytopenic purpura as the presenting manifestation in systemic lupus erythematosus,” Marquette Medical Review, vol. 27, pp. 6–12, 1961. View at Google Scholar
  12. A. D. Steinberg, W. T. Green Jr., and N. Talal, “Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome,” The Journal of the American Medical Association, vol. 215, no. 5, pp. 757–761, 1971. View at Google Scholar
  13. M.-L. John and I. Scharrer, “Autoimmune disorders in patients with idiopathic thrombotic thrombocytopenic purpura,” Hamostaseologie, vol. 32, supplement 1, pp. S86–S89, 2012. View at Google Scholar · View at Scopus
  14. K. Walter, J. Vaughn, and D. Martin, “Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency,” BMC Hematology, vol. 15, no. 1, article 16, 2015. View at Publisher · View at Google Scholar
  15. A. K. Tadakamalla, S. K. Talluri, and S. Besur, “Pseudo-thrombotic thrombocytopenic purpura: a rare presentation of pernicious anemia,” North American Journal of Medical Sciences, vol. 3, no. 10, pp. 472–474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Abbott, K. D. Friedman, and M. S. Karafin, “Differentiation of pernicious anemia from thrombotic thrombocytopenic purpura: the clinical value of subtle pathologic findings,” Transfusion and Apheresis Science, vol. 55, no. 3, pp. 318–322, 2016. View at Publisher · View at Google Scholar
  17. M. Malla and M. Seetharam, “To treat or not to treat: a rare case of pseudo-thrombotic thrombocytopenic purpura in a Jehovah's Witness,” Transfusion, vol. 56, no. 1, pp. 160–163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Panchabhai, P. Patil, E. Riley, and C. Mitchell, “When the picture is fragmented: vitamin B12 deficiency masquerading as thrombotic thrombocytopenic purpura,” International Journal of Critical Illness and Injury Science, vol. 6, no. 2, pp. 89–92, 2016. View at Publisher · View at Google Scholar
  19. J. Heward and S. C. L. Gough, “Genetic susceptibility to the development of autoimmune disease,” Clinical Science, vol. 93, no. 6, pp. 479–491, 1997. View at Google Scholar · View at Scopus
  20. B. Changcharoen and D. T. Bolger Jr., “Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody,” BMJ Case Reports, vol. 2015, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Abu-Hishmeh, A. Sattar, F. Zarlasht et al., “Systemic Lupus erythematosus presenting as refractory thrombotic thrombocytopenic purpura: a diagnostic and management challenge. a case report and concise review of the literature,” American Journal of Case Reports, vol. 17, pp. 782–787, 2016. View at Publisher · View at Google Scholar
  22. A. Toumeh, N. Josh, R. Narwal, and R. Assaly, “Refractory thrombotic thrombocytopenic purpura associated with primary sjogren syndrome treated with rituximab: a case report,” American Journal of Therapeutics, vol. 21, no. 2, pp. e56–e60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Abe, N. Tsuboi, S. Yukawa et al., “Thrombotic thrombocytopenic purpura complicating Sjögren's syndrome with crescentic glomerulonephritis and membranous nephritis,” Modern Rheumatology, vol. 14, no. 2, pp. 174–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Schattner, J. Friedman, and A. Klepfish, “Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjögren's syndrome,” Clinical Rheumatology, vol. 21, no. 1, pp. 57–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Yoshida, A. Todo, S. Shirakawa, G. Wakisaka, and H. Uchino, “Proliferation of megaloblasts in pernicious anemia as observed from nucleic acid metabolism,” Blood, vol. 31, no. 3, pp. 292–303, 1968. View at Google Scholar · View at Scopus
  26. M. J. Koury, J. O. Price, and G. G. Hicks, “Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism,” Blood, vol. 96, no. 9, pp. 3249–3255, 2000. View at Google Scholar · View at Scopus
  27. E. B. Healton, D. G. Savage, J. C. M. Brust, T. J. Garrett, and J. Lindenbaum, “Neurologic aspects of cobalamin deficiency,” Medicine, vol. 70, no. 4, pp. 229–245, 1991. View at Google Scholar · View at Scopus
  28. W. G. Thompson, C. Cassino, L. Bahitz et al., “Hypersegmented neutrophils and vitamin B12 deficiency. Hypersegmentation in B12 deficiency,” Acta Haematologica, vol. 81, no. 4, pp. 186–191, 1989. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Andrès, S. Affenberger, J. Zimmer et al., “Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency,” Clinical and Laboratory Haematology, vol. 28, no. 1, pp. 50–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Olinescu, F. A. Kummerow, B. Handler, and L. Fleischer, “The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes,” Biochemical and Biophysical Research Communications, vol. 226, no. 3, pp. 912–916, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Ventura, R. Panini, S. Tremosini, and G. Salvioli, “A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B12 and folate deficiency: results from an in vitro experience,” Biochimica et Biophysica Acta, vol. 1739, no. 1, pp. 33–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Zittan, M. Preis, I. Asmir et al., “High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 1, pp. H860–H865, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Nappo, N. De Rosa, R. Marfella et al., “Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins,” Journal of the American Medical Association, vol. 281, no. 22, pp. 2113–2118, 1999. View at Publisher · View at Google Scholar · View at Scopus